mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.01 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.02 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |